Dupilumab Versus Topical Corticosteroid Effectiveness - Comparison in the Treatment of Stenotic EoE

Abroad (travel likely)RecruitingPHASE2

Conditions

Eosinophilic Esophagitis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Children's Hospital Colorado/University of Colorado School of Medicine, Aurora, Colorado, United States
Contact: Study coordinator (Clinical Research Supervisor | Digestive Health Institute) · michelle.landis@childrenscolorado.org · 720-777-8884

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis

Eosinophilic Esophagitis (EoE)

Abroad (travel likely)RecruitingPHASE3

Phoenix, United States · San Francisco, United States

A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Care

Eosinophilic Esophagitis (EoE)

Abroad (travel likely)Recruiting

Phoenix, United States · Sun City, United States

A Non-interventional Observational Study to Assess Long-term Efficacy and Safety of Dupilumab for the Treatment of Patients (>= 12 Years) With Eosinophilic Esophagitis Under Real-world-conditions in Germany

Eosinophilic Esophagitis

Abroad (travel likely)Recruiting

Dachau, Germany

A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE).

Eosinophilic Esophagitis

Abroad (travel likely)RecruitingPHASE1, PHASE2

Sydney, Australia · Brisbane, Australia